neuralgap.io

Integrated Molecular Analysis

Unified analysis across multiple molecular dimensions.

Our state-of-the-art Multi-Unimodal Architecture rethinks drug discovery by analyzing multiple types of molecular interactions simultaneously.

By processing multiple modalities – everything from structural properties to dynamic binding patterns – we are creating a framework for pharma startups to create more refined, ‘context-aware’ drug candidates.

Adaptability
The MUM architecture forms the base of Genesys, and its ability to learn without distribution shifts enables new modalities to be bolted on.

Discovery Efficiency
Multiple ‘versions’ of the models can be created, from very heavy to light weight depending on the stage of the pipeline.

The Multi-Uni-Modal Architecture

Redefining Molecular Intelligence

Unified Processing

Seamless integration of multiple molecular representations
Real-time synchronization of structural and dynamic data
Advanced pattern recognition across binding modalities

Adaptive Learning

Training on unpaired, asynchronous molecular data
Continuous improvement from real-world screening results
Flexible adaptation to discovery workflows

Intelligent Scaling

More than 50% reduction in computational parameters
Superior accuracy with fewer training compounds
Seamless integration of new molecular descriptors

Your Discovery Command Center

Complex Analysis Made Simple.

Manage your compounds from an intuitive interface that brings together structural analysis, dynamic simulations, and binding predictions in one place.

In one platform;

– Track screening progress
– Analyze results
– Identify promising leads

Genesys: Multimodal Virtual Screening